Gut solutions to a gut problem: bacteriocins, probiotics and bacteriophage for control of Clostridium difficile infection

Oral and Rectal Administration of Bacteriophages for Control of Escherichia coli O157:H7 in Feedlot Cattle

(2016) ERICA A. ROZEMA et al.   JOURNAL OF FOOD PROTECTION

Contrasting effects of Bifidobacterium breve NCIMB 702258 and Bifidobacterium breve DPC 6330 on the composition of murine brain fatty acids and gut microbiota

(2012) Rebecca Wall et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

ComparativeIn VitroActivities of LFF571 against Clostridium difficile and 630 Other Intestinal Strains of Aerobic and Anaerobic Bacteria

(2012) Diane M. Citron et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Evidence ofIn VivoProphage Induction during Clostridium difficile Infection

(2012) Mathieu Meessen-Pinard et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Prophage Carriage and Diversity within Clinically Relevant Strains of Clostridium difficile

(2012) Jinyu Shan et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Shiga Toxin-Producing Escherichia coli O104:H4: a New Challenge for Microbiology

(2012) Maite Muniesa et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Generation of an actagardine A variant library through saturation mutagenesis

(2012) Steven Boakes et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Resistance is futile: the bacteriocin model for addressing the antibiotic resistance challenge

(2012) Margaret A. Riley et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Is primary prevention of Clostridium difficile infection possible with specific probiotics?

(2012) Stuart Johnson et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Fidaxomicin: a new option for the treatment of Clostridium difficile infection

(2012) A. P. Johnson et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection

(2012) P.N. Wiegand et al.   JOURNAL OF HOSPITAL INFECTION

Diverse Temperate Bacteriophage Carriage in Clostridium difficile 027 Strains

(2012) Janet Y. Nale et al.   PLoS One

Selection and Characterization of a Candidate Therapeutic Bacteriophage That Lyses the Escherichia coli O104:H4 Strain from the 2011 Outbreak in Germany

(2012) Maia Merabishvili et al.   PLoS One

The gut is the epicentre of antibiotic resistance

(2012) Jean Carlet   Antimicrobial Resistance and Infection Control

In vivo lysogenization of a Clostridium difficile bacteriophage ФCD119

(2011) Govind Revathi et al.   ANAEROBE

Bacteriocin Production: a Probiotic Trait?

(2011) Alleson Dobson et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Potential of Bacteriophages and Their Lysins in the Treatment of MRSA

(2011) Jan Borysowski et al.   BIODRUGS

Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens

(2011) Ben Burrowes et al.   Expert Review of Anti-Infective Therapy

Antibiotic Treatment Alters the Colonic Mucus Layer and Predisposes the Host to ExacerbatedCitrobacter rodentium-Induced Colitis

(2011) M. Wlodarska et al.   INFECTION AND IMMUNITY

Assessment of Escherichia coli O157:H7-specific bacteriophages e11/2 and e4/1c in model broth and hide environments

(2011) Brid Coffey et al.   INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY

Prophage-Stimulated Toxin Production in Clostridium difficile NAP1/027 Lysogens

(2011) O. Sekulovic et al.   JOURNAL OF BACTERIOLOGY

Structure-Based Modification of a Clostridium difficile-Targeting Endolysin Affects Activity and Host Range

(2011) M. J. Mayer et al.   JOURNAL OF BACTERIOLOGY

Clostridium difficile Carriage in Elderly Subjects and Associated Changes in the Intestinal Microbiota

(2011) M. C. Rea et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Dose–Response Efficacy of a Proprietary Probiotic Formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for Antibiotic-Associated Diarrhea and Clostridium difficile-Associated Diarrhea Prophylaxis in Adult Patients

(2010) Xing Wang Gao et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Bacteriophage treatment significantly reduces viable Clostridium difficile and prevents toxin production in an in vitro model system

(2010) Emma Meader et al.   ANAEROBE

The Changing Epidemiology of Clostridium difficile Infections

(2010) J. Freeman et al.   CLINICAL MICROBIOLOGY REVIEWS

The colonic microflora and probiotic therapy in health and disease

(2010) Fergus Shanahan   CURRENT OPINION IN GASTROENTEROLOGY

Genome analysis of the Clostridium difficile phage ΦCD6356, a temperate phage of the Siphoviridae family

(2010) Marianne Horgan et al.   GENE

Durable Alteration of the Colonic Microbiota by the Administration of Donor Fecal Flora

(2010) Martin J. Grehan et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Fecal Flora Reconstitution for Recurrent Clostridium difficile Infection: Results and Methodology

(2010) Faith Rohlke et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Economic healthcare costs of Clostridium difficile infection: a systematic review

(2010) S.S. Ghantoji et al.   JOURNAL OF HOSPITAL INFECTION

Bacteriophages Can Treat and PreventPseudomonas aeruginosaLung Infections

(2010) Laurent Debarbieux et al.   JOURNAL OF INFECTIOUS DISEASES

Pathogenic C difficile is here (and everywhere) to stay

(2010) Cirle A Warren et al.   LANCET

A human gut microbial gene catalogue established by metagenomic sequencing

(2010) Junjie Qin et al.   NATURE

Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile

(2010) M. C. Rea et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon

(2010) M. C. Rea et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Studies with bioengineered Nisin peptides highlight the broad-spectrum potency of Nisin V

(2010) Des Field et al.   Microbial Biotechnology

The fascination with probiotics for Clostridium difficile infection: Lack of evidence for prophylactic or therapeutic efficacy

(2009) Mark Miller   ANAEROBE

Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections

(2009) Lynne V. McFarland   ANAEROBE

A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistantPseudomonas aeruginosa; a preliminary report of efficacy

(2009) A. Wright et al.   CLINICAL OTOLARYNGOLOGY

Antimicrobial resistance in Clostridium difficile

(2009) Haihui Huang et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Asymptomatic carriage of Clostridium difficile in an Irish continuing care institution for the elderly: prevalence and characteristics

(2009) J. Ryan et al.   IRISH JOURNAL OF MEDICAL SCIENCE

Gastrointestinal microflora, food components and colon cancer prevention

(2009) Cindy D. Davis et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Clostridium difficile infection: new developments in epidemiology and pathogenesis

(2009) Maja Rupnik et al.   NATURE REVIEWS MICROBIOLOGY

Antibiotic-Resistant Bugs in the 21st Century — A Clinical Super-Challenge

(2009) Cesar A. Arias et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bacteriophage lysins as effective antibacterials

(2008) Vincent A Fischetti   CURRENT OPINION IN MICROBIOLOGY

Emergence of reduced susceptibility to metronidazole in Clostridium difficile

(2008) S. D. Baines et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Molecular Characterization of a Clostridium difficile Bacteriophage and Its Cloned Biologically Active Endolysin

(2008) M. J. Mayer et al.   JOURNAL OF BACTERIOLOGY

Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits

(2008) Katharina Brandl et al.   NATURE